Acelyrin (SLRN) Adopts Limited-Duration Stockholder Rights Plan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. FLG
5. GMAB
6. QQQ
7. TSLA
8. SPCX
9. AZN
10. APO

Go back to Acelyrin (SLRN) Adopts Limited-Duration Stockholder Rights Plan

ACELYRIN Adopts Limited-Duration Stockholder Rights Plan

March 13, 2025 7:00 AM EDT

LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that, in response to Tang Capital Partners continued rapid accumulation of 8.8% of ACELYRINS outstanding common stock, its Board of Directors has approved the adoption of a limited-duration stockholder rights plan (Rights Plan).

The ACELYRIN Board and management team continue to engage with stockholders and are focused on maximizing stockholder value.

Pursuant to the Rights Plan, the Company is... More